top of page

Register for "Understanding Treatments for Neuroendocrine Tumors, and Rationale for Sequencing of Therapy" >>>

Home
About Us
Education
Support for Patients & Caregivers
Resources
Clinical Trials
Podcast
More

Use tab to navigate through the menu items.

Pheochromocytoma/ Paraganglioma

Pheochromocytoma/ Paraganglioma

Alpha PRRT with Pb-212 VMT
Antibody Drug Conjugate ADCT-701 in Neuroendocrine Tumors and Carcinomas
Belzutifan/MK-6482 in PNET + PPGL + VHL
IL13Rα2 CAR T Cell Study for Solid Tumor Cancers
Olaparib + Usual Chemotherapy (Temozolomide) in PPGL
NETTER-P: Lutathera in Adolescent Patients
LAMPARA: LAnreotide in Metastatic Pheochromocytoma/PARAganglioma

NEUROENDOCRINE CANCER FOUNDATION

PO BOX 370466

DENVER, CO 80237

info@ncf.net

TERMS & CONDITIONS

© 2025 by Neuroendocrine Cancer Foundation

bottom of page